by Jordana Choucair | Dec 2, 2022 | Life Sciences
Pfizer Inc. plans to invest more than $2.5 billion in manufacturing plants in Belgium and Ireland. The company hopes that developing new products will offset losses from expiring patents and declining COVID-19 vaccine sales. (Article here)
by Jordana Choucair | Dec 2, 2022 | Life Sciences
Merck & Co. could maintain patents for its best-selling drug Keytruda by patenting an injectable form of the medicine, which it’s currently testing in clinical trials. Certain patents for Keytruda are up in 2028, when copies of the drug could hit the market....
by Jordana Choucair | Dec 2, 2022 | Mental Health
The nation’s new 988 hotline, intended to help anyone experiencing a mental health emergency, was out of service for several hours Thursday. Intrado, the telecommunications provider for the service, issued a statement on its website saying that the company was...
by Jordana Choucair | Dec 2, 2022 | Opioid/Substance Use Disorders
A bipartisan bill to increase access to treatment for opioid addiction has a good chance of being rolled into a year-end package during the lame-duck session. The bill would remove a requirement that health care providers get a special waiver from the Drug Enforcement...
by Jordana Choucair | Dec 2, 2022 | Providers
A coalition of physician groups led by the American Medical Association asked a Texas judge not to implement a nationwide injunction on a key portion of the Affordable Care Act (ACA) that covers preventive services. In September, the judge ruled that the...
Recent Comments